March 29, 2017 / 5:56 AM / 5 months ago

Stada says fourth-quarter adjusted net income slips 4 percent

The logo of the pharmaceutical company Stada Arzneimittel AG is pictured at its headquarters in Bad Vilbel near Frankfurt March 14, 2012.Alex Domanski

FRANKFURT (Reuters) - German drugmaker Stada (STAGn.DE), at the centre of a takeover battle between two private equity consortia, said fourth-quarter adjusted net income slipped 4 percent, revising lower preliminary unaudited results it posted earlier this month after fully taking into account a smaller acquisition.

Stada, which also makes branded non-prescription treatments and diagnostic kits, said quarterly adjusted net income declined to 37.4 million euros (32.57 million pounds), down from 38.9 million a year earlier.

It had initially reported a figure of 44 million euros.

In its statement on Wednesday, Stada did not comment on the takeover bids. It is due to hold a press conference at 0730 GMT.

The German company confirmed its targets for 2017 and 2019.

Reporting by Ludwig Burger; Editing by Victoria Bryan

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below